Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work
Effective management of diarrhea during weight loss injection therapy requires a systematic approach addressing both medication factors and lifestyle modifications
PlexusDx delivers fully reconstituted semaglutide injections ready to use immediately upon arrival
Each receptor contributes something unique to the overall metabolic effect, and their combined activation produces outcomes that no single-receptor agonist can match
If youve been holding back due to stigma or misinformation, nows the time to reconsider